Safety of ustekinumab in severe psoriasis with chronic hepatitis B

Indian Journal of Dermatology, Venereology and Leprology

Volumn 82, Issue 3, 2016, Pages 326-328

  Raymundo, Anelise Rocha ^a   Facin, Ana Paula Berreta ^a   Silva De Castro, Caio César ^b   Faria, Adriane Reichert ^b  

^a Hospital Santa Casa de Curitiba   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ENTECAVIR; ETRETIN; METHOTREXATE; USTEKINUMAB; DERMATOLOGICAL AGENT;

ADULT; ANTIVIRAL THERAPY; CASE REPORT; CHRONIC HEPATITIS B; DISEASE SEVERITY; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; MIDDLE AGED; PSORIASIS VULGARIS; TREATMENT OUTCOME; VIRUS LOAD; COMPLICATION; DRUG EFFECTS; HEPATITIS B, CHRONIC; PSORIASIS; SEVERITY OF ILLNESS INDEX;

DERMATOLOGIC AGENTS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; PSORIASIS; SEVERITY OF ILLNESS INDEX; USTEKINUMAB; VIRAL LOAD;

EID: 84964786451     PISSN: 03786323     EISSN: 09733922     Source Type: Journal    
DOI: 10.4103/0378-6323.174393     Document Type: Letter

References (5)

1. Koskinas J, Tampaki M, Doumba PP, Rallis E. Hepatitis B virus reactivation during therapy with ustekinumab for psoriasis in a hepatitis B surface-antigen-negative anti-HBs-positive patient. Br J Dermatol 2013;168:679-80.
2. Navarro R, Vilarrasa E, Herranz P, Puig L, Bordas X, Carrascosa JM, Taberner R, Ferrán M, García-Bustinduy M, Romero-Maté A, Pedragosa R, García-Diez A, Daudén E. Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: A retrospective, multicentre study in a clinical setting. Br J Dermatol 2013;168 (3):609-16.
3. Warren RB, Al-Rifai A. Treatment of severe psoriasis with biological therapies in patients with viral hepatitis B and C. Br Assoc Dermatol 2013;168:461-2.
4. Steglich RB, Meneghello LP, Carvalho AV, Cheinquer H, Muller FM, Reginatto FP. The use of ustekinumab in a patient with severe psoriasis and positive HBV serology. An Bras Dermatol 2014;89:652-4.
5. Mastroianni CM, Lichtner M, Citton R, Del Borgo C, Rago A, Martini H, et al. Current trends in management of hepatitis B virus reactivation in the biologic therapy era. World J Gastroenterol 2011;17:3881-7.